litlas
ログインアカウント作成

James L. Riley

1994–2025 年に発表

95
論文数
24,879
被引用数
77
h 指数
90
i10 指数

被引用数

James L. Riley の年別被引用数1990 年: 被引用 1 件1995 年: 被引用 4 件1996 年: 被引用 8 件1997 年: 被引用 32 件1998 年: 被引用 68 件1999 年: 被引用 47 件2000 年: 被引用 57 件2001 年: 被引用 42 件2002 年: 被引用 70 件2003 年: 被引用 77 件2004 年: 被引用 116 件2005 年: 被引用 122 件2006 年: 被引用 113 件2007 年: 被引用 122 件2008 年: 被引用 128 件2009 年: 被引用 211 件2010 年: 被引用 250 件2011 年: 被引用 265 件2012 年: 被引用 303 件2013 年: 被引用 405 件2014 年: 被引用 343 件2015 年: 被引用 434 件2016 年: 被引用 392 件2017 年: 被引用 437 件2018 年: 被引用 452 件2019 年: 被引用 971 件2020 年: 被引用 1,108 件2021 年: 被引用 1,104 件2022 年: 被引用 915 件2023 年: 被引用 660 件2024 年: 被引用 835 件2025 年: 被引用 526 件2026 年: 被引用 15 件1991〜1994 年は被引用が無いため表示していません

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 4,438 件、この内訳の 37.5%中国: 引用元論文 1,455 件、この内訳の 12.3%ドイツ: 引用元論文 686 件、この内訳の 5.8%イギリス: 引用元論文 670 件、この内訳の 5.7%フランス: 引用元論文 374 件、この内訳の 3.2%カナダ: 引用元論文 357 件、この内訳の 3%イタリア: 引用元論文 352 件、この内訳の 3%日本: 引用元論文 317 件、この内訳の 2.7%オーストラリア: 引用元論文 265 件、この内訳の 2.2%スイス: 引用元論文 249 件、この内訳の 2.1%オランダ: 引用元論文 245 件、この内訳の 2.1%スペイン: 引用元論文 207 件、この内訳の 1.7%
0%37.5%その他 18.7%

機関

分野

  • Medicine51.7%
  • Immunology and Microbiology31.2%
  • Biochemistry, Genetics and Molecular Biology15%
  • Neuroscience0.9%
  • Engineering0.4%
  • Agricultural and Biological Sciences0.2%
  • その他0.6%

トピック

  • Immune Cell Function and Interaction13.3%
  • CAR-T cell therapy research11.7%
  • Immunotherapy and Immune Responses8%
  • T-cell and B-cell Immunology7.7%
  • Cancer Immunotherapy and Biomarkers7.6%
  • Virus-based gene therapy research3.2%
  • その他48.5%

共著者

全論文

検索で開く
  1. PSMA-targeting TGFβ-insensitive armored CAR T cells in metastatic castration-resistant prostate cancer: a phase 1 trial

    著者: Vivek Narayan, Julie S. Barber-Rotenberg, In-Young Jung, Simon F. Lacey, Andrew J. Rech, Megan M. Davis, Wei‐Ting Hwang, Priti Lal, Erica L. Carpenter, Shannon L. Maude, Gabriela Plesa, Neha Vapiwala, Anne Chew, Michael Moniak, Ronnie Sebro, Michael D. Farwell, Amy Marshall, Joan Gilmore, Lester Lledo, Karen Dengel, S. Church, Tyler Hether, Jun Xu, Mercy Gohil, Thomas H. Buckingham, Stephanie S. Yee, Vanessa Gonzalez, Irina Kulikovskaya, Fang Chen, Lifeng Tian, Kyle Tien, Whitney L. Gladney, Christopher L. Nobles, Hayley E. Raymond, Prostate Cancer Cellular Therapy Program Investigators, Diane Frazee, Mary Truran, Elizabeth Veloso, Holly McConville, Jonathan Aguedelo, Samantha Hower, Sophia Ngo, Julie K. Jadlowsky, J. Joseph Melenhorst, Aoife M. Roche, J.K. Everett, Minnal Gupta, Farzana Nazimuddin, Chelsie Bartoszek, Natalka Koterba, Rachael Reynolds, Farris Ellington, Christopher C. Kloss, Ji‐Hyun Lee, Yangbing Zhao, John Scholler, James L. Riley, Christina Bailey, Andrew J. P. White, Briana M. Hudson, Pearl Chang, Marcela V. Maus, Bruce L. Levine, Elizabeth O. Hexner, Donald L. Siegel, Frederic D. Bushman, Carl H. June, Joseph A. Fraietta, Naomi B. Haas - Nature Medicine 2022 被引用: 500

  2. CTLA-4 and PD-1 Receptors Inhibit T-Cell Activation by Distinct Mechanisms

    著者: Richard V. Parry, Jens M. Chemnitz, Kenneth A. Frauwirth, Anthony R. Lanfranco, Inbal Braunstein, Sumire Kobayashi, Peter S. Linsley, Craig B. Thompson, James L. Riley - Molecular and Cellular Biology 2005 被引用: 1,902

  3. The CD28 Signaling Pathway Regulates Glucose Metabolism

    著者: Kenneth A. Frauwirth, James L. Riley, Marian H. Harris, Richard V. Parry, Jeffrey C. Rathmell, David R. Plas, Rebecca Elstrom, Carl H. June, Craig B. Thompson - Immunity 2002 被引用: 1,441

  4. Chimeric Receptors Containing CD137 Signal Transduction Domains Mediate Enhanced Survival of T Cells and Increased Antileukemic Efficacy In Vivo

    著者: Michael C. Milone, Jonathan D. Fish, Carmine Carpenito, Richard G. Carroll, Gwendolyn K. Binder, David T. Teachey, Minu Samanta, Mehdi Lakhal, Brian Gloss, Gwenn Danet-Desnoyers, Dario Campana, James L. Riley, Stephan A. Grupp, Carl H. June - Molecular Therapy 2009 被引用: 1,189

  5. SHP-1 and SHP-2 Associate with Immunoreceptor Tyrosine-Based Switch Motif of Programmed Death 1 upon Primary Human T Cell Stimulation, but Only Receptor Ligation Prevents T Cell Activation

    著者: Jens M. Chemnitz, Richard V. Parry, Kim E. Nichols, Carl H. June, James L. Riley - The Journal of Immunology 2004 被引用: 1,231

  6. Role of PD-1 during effector CD8 T cell differentiation

    著者: Eunseon Ahn, Koichi Araki, Masao Hashimoto, Weiyan Li, James L. Riley, Jeanne Cheung, Arlene H. Sharpe, Gordon J. Freeman, Bryan Irving, Rafi Ahmed - National Academy of Sciences, Proceedings of the National Academy of Sciences 2018 被引用: 482

  7. Identification of a Titin-Derived HLA-A1–Presented Peptide as a Cross-Reactive Target for Engineered MAGE A3–Directed T Cells

    著者: Brian Cameron, Andrew B. Gerry, Joseph Dukes, Jane Harper, Vivekanandan Kannan, Frayne Bianchi, Francis Grand, Joanna E. Brewer, Minnal Gupta, Gabriela Plesa, Giovanna Bossi, Annelise Vuidepot, Alex S. Powlesland, Alison Legg, Katherine J. Adams, Alan Bennett, Nicholas J. Pumphrey, Daniel Williams, Gwendolyn Binder-Scholl, Irina Kulikovskaya, Bruce L. Levine, James L. Riley, Angel Varela‐Rohena, Edward A. Stadtmauer, Aaron P. Rapoport, Gerald P. Linette, Carl H. June, Namir J. Hassan, Michael Kalos, Bent K. Jakobsen - Science Translational Medicine 2013 被引用: 677

  8. PD‐1 signaling in primary T cells

    著者: James L. Riley - Immunological Reviews 2009 被引用: 769

  9. Control of large, established tumor xenografts with genetically retargeted human T cells containing CD28 and CD137 domains

    著者: Carmine Carpenito, Michael C. Milone, Raffit Hassan, Jacqueline C. Simonet, Mehdi Lakhal, Megan M. Suhoski, Angel Varela‐Rohena, Kathleen M. Haines, Daniel F. Heitjan, Steven Μ. Albelda, Richard G. Carroll, James L. Riley, Ira Pastan, Carl H. June - National Academy of Sciences, Proceedings of the National Academy of Sciences 2009 被引用: 889

  10. Genetic engineering of T cells for immunotherapy

    著者: Gavin I. Ellis, Neil C. Sheppard, James L. Riley - Nature Reviews Genetics 2021 被引用: 159

  11. Chronic Virus Infection Enforces Demethylation of the Locus that Encodes PD-1 in Antigen-Specific CD8+ T Cells

    著者: Ben Youngblood, Kenneth J. Oestreich, Sang‐Jun Ha, Jaikumar Duraiswamy, Rama Akondy, Erin E. West, Zhengyu Wei, Peiyuan Lu, James W. Austin, James L. Riley, Jeremy M. Boss, Rafi Ahmed - Immunity 2011 被引用: 408

  12. Dual CD4-based CAR T cells with distinct costimulatory domains mitigate HIV pathogenesis in vivo

    著者: Colby R. Maldini, Daniel T. Claiborne, Ken Okawa, Tao Chen, Derrick L. Dopkin, Xiaochuan Shan, Karen A. Power, Radiana Trifonova, Katharine L. Krupp, Meredith Phelps, Vladimir Vrbanac, Serah Tanno, Timothy Bateson, George J. Leslie, James A. Hoxie, Christian L. Boutwell, James L. Riley, Todd M. Allen - Nature Medicine 2020 被引用: 126

  13. The PDL1-PD1 Axis Converts Human T H 1 Cells into Regulatory T Cells

    著者: Shoba Amarnath, Courtney W. Mangus, James C.M. Wang, Fang Wei, Alice He, Veena Kapoor, Jason Foley, Paul R. Massey, Tania C. Felizardo, James L. Riley, Bruce L. Levine, Carl H. June, Jeffrey A. Medin, Daniel H. Fowler - Science Translational Medicine 2011 被引用: 440

  14. Decade-Long Safety and Function of Retroviral-Modified Chimeric Antigen Receptor T Cells

    著者: John Scholler, Troy Brady, Gwendolyn Binder-Scholl, Wei‐Ting Hwang, Gabriela Plesa, Kristen Hege, Ashley N. Vogel, Michael Kalos, James L. Riley, Steven G. Deeks, Ronald T. Mitsuyasu, Wendy B. Bernstein, Naomi Aronson, Bruce L. Levine, Frederic D. Bushman, Carl H. June - Science Translational Medicine 2012 被引用: 647

  15. Expression of a Functional CCR2 Receptor Enhances Tumor Localization and Tumor Eradication by Retargeted Human T cells Expressing a Mesothelin-Specific Chimeric Antibody Receptor

    著者: Edmund K. Moon, Carmine Carpenito, Jing Sun, Liang‐Chuan S. Wang, Veena Kapoor, Jarrod D. Predina, Daniel J. Powell, James L. Riley, Carl H. June, Steven Μ. Albelda - Clinical Cancer Research 2011 被引用: 521

  16. CAR T cells for infection, autoimmunity and allotransplantation

    著者: Colby R. Maldini, Gavin I. Ellis, James L. Riley - Nature reviews. Immunology 2018 被引用: 231

  17. Multifactorial T-cell Hypofunction That Is Reversible Can Limit the Efficacy of Chimeric Antigen Receptor–Transduced Human T cells in Solid Tumors

    著者: Edmund K. Moon, Liang-Chuan Wang, Douglas V. Dolfi, Caleph B. Wilson, Raghuveer Ranganathan, Jing Sun, Veena Kapoor, John Scholler, Ellen Puré, Michael C. Milone, Carl H. June, James L. Riley, E. John Wherry, Steven Μ. Albelda - Clinical Cancer Research 2014 被引用: 410

  18. Umbilical cord blood–derived T regulatory cells to prevent GVHD: kinetics, toxicity profile, and clinical effect

    著者: Claudio G. Brunstein, Jeffrey S. Miller, David H. McKenna, Keli L. Hippen, Todd E. DeFor, Darin Sumstad, Julie Curtsinger, Michael R. Verneris, Margaret L. MacMillan, Bruce L. Levine, James L. Riley, Carl H. June, Chap T. Le, Daniel J. Weisdorf, Philip B. McGlave, Bruce R. Blazar, John E. Wagner - Blood 2015 被引用: 401

  19. CCR5-edited CD4+ T cells augment HIV-specific immunity to enable post-rebound control of HIV replication

    著者: Pablo Tebas, Julie K. Jadlowsky, Pamela A. Shaw, Lifeng Tian, Erin Esparza, Andrea Brennan, Su Kyung Kim, Soe Yu Naing, Max W. Richardson, Ashley N. Vogel, Colby R. Maldini, Hong Kong, Xiaojun Liu, Simon F. Lacey, Anya M. Bauer, Felicity Mampe, Lee P. Richman, Gary Lee, Dale Ando, Bruce L. Levine, David L. Porter, Yangbing Zhao, Don L. Siegel, Katharine J. Bar, Carl H. June, James L. Riley - Journal of Clinical Investigation 2021 被引用: 98

  20. CD25 Blockade Depletes and Selectively Reprograms Regulatory T Cells in Concert with Immunotherapy in Cancer Patients

    著者: Andrew J. Rech, Rosemarie Mick, Sunil Martin, Adri Recio, Nicole A. Aqui, Daniel J. Powell, Theresa A. Colligon, Jennifer A. Trosko, Leah I. Leinbach, Charles H. Pletcher, Carol Tweed, Angela DeMichele, Kevin R. Fox, Susan M. Domchek, James L. Riley, Robert H. Vonderheide - Science Translational Medicine 2012 被引用: 328

  21. Lack of immunoediting in murine pancreatic cancer reversed with neoantigen

    著者: Rebecca A. Evans, Mark S. Diamond, Andrew J. Rech, Timothy Chao, Max W. Richardson, Jeffrey Lin, David L. Bajor, Katelyn T. Byrne, Ben Z. Stanger, James L. Riley, Nune Markosyan, Rafael Winograd, Robert H. Vonderheide - JCI Insight 2016 被引用: 181

  22. Establishment of HIV-1 resistance in CD4+ T cells by genome editing using zinc-finger nucleases

    著者: Elena Pérez, Jianbin Wang, Jeffrey C. Miller, Yann Jouvenot, Kenneth A Kim, Olga Liu, Nathaniel Wang, Gary Lee, Victor V. Bartsevich, Ya-Li Lee, Dmitry Guschin, Igor Rupniewski, Adam James Waite, Carmine Carpenito, Richard G. Carroll, Jordan S. Orange, Fyodor D. Urnov, Edward J. Rebar, Dale Ando, Philip D. Gregory, James L. Riley, Michael C. Holmes, Carl H. June - Nature Biotechnology 2008 被引用: 999

  23. Strength of PD-1 signaling differentially affects T-cell effector functions

    著者: Fang Wei, Zhong Shi, Zhengyu Ma, Hong Kong, Andrew Medvec, Rafi Ahmed, Gordon J. Freeman, Michelle Krogsgaard, James L. Riley - National Academy of Sciences, Proceedings of the National Academy of Sciences 2013 被引用: 300

  24. Long-term safety of lentiviral or gammaretroviral gene-modified T cell therapies

    著者: Julie K. Jadlowsky, Elizabeth O. Hexner, Amy Marshall, Stephan A. Grupp, Noelle V. Frey, James L. Riley, Elizabeth Veloso, Holly McConville, Walter Rogal, Cory Czuczman, Wei‐Ting Hwang, Yimei Li, Rachel Leskowitz, Olivia Farrelly, Jayashree Karar, Shannon Christensen, Julie S. Barber-Rotenberg, Avery L. Gaymon, Naomi Aronson, Wendy Bernstein, J. Joseph Melenhorst, Aoife M. Roche, J.K. Everett, Sonja A. Zolnoski, Alexander McFarland, Shantan Reddy, Angelina Petrichenko, Emma J. Cook, Carole Lee, Vanessa Gonzalez, Kathleen A. Alexander, Irina Kulikovskaya, Ángel Ramírez-Fernández, Janna Minehart, Marco Ruella, Saar Gill, Stephen J. Schuster, Adam D. Cohen, Alfred L. Garfall, Payal D. Shah, David L. Porter, Shannon L. Maude, Bruce L. Levine, Don L. Siegel, Anne Chew, S.J. McKenna, Lester Lledo, Megan M. Davis, Gabriela Plesa, Friederike Herbst, Edward A. Stadtmauer, Pablo Tebas, Amanda M. DiNofia, A. Haas, Naomi B. Haas, Regina M. Myers, Donald M. O’Rourke, Jakub Svoboda, János L. Tanyi, Richard Aplenc, Jeffrey M. Jacobson, Andrew H. Ko, Roger B. Cohen, Carl H. June, Frederic D. Bushman, Joseph A. Fraietta - Nature Medicine 2025 被引用: 71